Logo image of PFHD

PROFESSIONAL HOLDING CORP-A (PFHD) Stock Fundamental Analysis

NASDAQ:PFHD - US7431391074 - Common Stock

28.65 USD
-0.15 (-0.52%)
Last: 1/31/2023, 8:00:01 PM
28.65 USD
0 (0%)
After Hours: 1/31/2023, 8:00:01 PM
Fundamental Rating

3

Overall PFHD gets a fundamental rating of 3 out of 10. We evaluated PFHD against 395 industry peers in the Banks industry. PFHD may be in some trouble as it scores bad on both profitability and health. PFHD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PFHD was profitable.
Each year in the past 5 years PFHD has been profitable.
Of the past 5 years PFHD 4 years had a positive operating cash flow.
PFHD Yearly Net Income VS EBIT VS OCF VS FCFPFHD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

1.2 Ratios

PFHD has a Return On Assets of 0.86%. This is in the lower half of the industry: PFHD underperforms 78.84% of its industry peers.
PFHD has a Return On Equity of 9.03%. This is in the lower half of the industry: PFHD underperforms 79.63% of its industry peers.
Industry RankSector Rank
ROA 0.86%
ROE 9.03%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PFHD Yearly ROA, ROE, ROICPFHD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2 4 6 8

1.3 Margins

PFHD has a worse Profit Margin (23.58%) than 76.98% of its industry peers.
In the last couple of years the Profit Margin of PFHD has grown nicely.
The Operating Margin and Gross Margin are not available for PFHD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 23.58%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.95%
PM growth 5Y18.29%
GM growth 3YN/A
GM growth 5YN/A
PFHD Yearly Profit, Operating, Gross MarginsPFHD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 5 10 15 20 25

More info and screens

1

2. Health

2.1 Basic Checks

PFHD does not have a ROIC to compare to the WACC, probably because it is not profitable.
PFHD has more shares outstanding than it did 1 year ago.
PFHD has a worse debt/assets ratio than last year.
PFHD Yearly Shares OutstandingPFHD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 5M 10M
PFHD Yearly Total Debt VS Total AssetsPFHD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B 2.5B

2.2 Solvency

PFHD has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.10, PFHD is doing good in the industry, outperforming 71.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.43%
PFHD Yearly LT Debt VS Equity VS FCFPFHD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
PFHD Yearly Current Assets VS Current LiabilitesPFHD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.96% over the past year.
Measured over the past years, PFHD shows a very strong growth in Earnings Per Share. The EPS has been growing by 62.09% on average per year.
Looking at the last year, PFHD shows a quite strong growth in Revenue. The Revenue has grown by 19.67% in the last year.
PFHD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.50% yearly.
EPS 1Y (TTM)1.96%
EPS 3Y105.31%
EPS 5Y62.09%
EPS Q2Q%0%
Revenue 1Y (TTM)19.67%
Revenue growth 3Y44.94%
Revenue growth 5Y39.5%
Sales Q2Q%23.12%

3.2 Future

PFHD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.02% yearly.
The Revenue is expected to grow by 9.08% on average over the next years. This is quite good.
EPS Next Y48.75%
EPS Next 2Y21.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.61%
Revenue Next 2Y9.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PFHD Yearly Revenue VS EstimatesPFHD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PFHD Yearly EPS VS EstimatesPFHD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0.5 1 1.5 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.37, the valuation of PFHD can be described as rather expensive.
91.27% of the companies in the same industry are cheaper than PFHD, based on the Price/Earnings ratio.
PFHD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.84.
PFHD is valuated correctly with a Price/Forward Earnings ratio of 12.35.
Based on the Price/Forward Earnings ratio, PFHD is valued a bit more expensive than the industry average as 74.34% of the companies are valued more cheaply.
PFHD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.37
Fwd PE 12.35
PFHD Price Earnings VS Forward Price EarningsPFHD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PFHD Per share dataPFHD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PFHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PFHD's earnings are expected to grow with 21.02% in the coming years.
PEG (NY)0.38
PEG (5Y)0.3
EPS Next 2Y21.02%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PFHD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PROFESSIONAL HOLDING CORP-A

NASDAQ:PFHD (1/31/2023, 8:00:01 PM)

After market: 28.65 0 (0%)

28.65

-0.15 (-0.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-27 2023-01-27/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.6%
Ins Owner Change0%
Market Cap395.78M
Analysts48.89
Price Target30.26 (5.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.66%
Min EPS beat(2)-50.98%
Max EPS beat(2)3.65%
EPS beat(4)2
Avg EPS beat(4)-17.39%
Min EPS beat(4)-50.98%
Max EPS beat(4)28.16%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-9.53%
Max Revenue beat(2)3.65%
Revenue beat(4)3
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-9.53%
Max Revenue beat(4)8.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.6%
Valuation
Industry RankSector Rank
PE 18.37
Fwd PE 12.35
P/S 4.21
P/FCF N/A
P/OCF N/A
P/B 1.61
P/tB 1.8
EV/EBITDA N/A
EPS(TTM)1.56
EY5.45%
EPS(NY)2.32
Fwd EY8.1%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.8
BVpS17.76
TBVpS15.92
PEG (NY)0.38
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 0.86%
ROE 9.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.58%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.95%
PM growth 5Y18.29%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC8.43%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y105.31%
EPS 5Y62.09%
EPS Q2Q%0%
EPS Next Y48.75%
EPS Next 2Y21.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.67%
Revenue growth 3Y44.94%
Revenue growth 5Y39.5%
Sales Q2Q%23.12%
Revenue Next Year12.61%
Revenue Next 2Y9.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A